Activation of central ¦Á2-adrenoceptors mediates salivary gland vasoconstriction
详细信息    查看全文
文摘

Objective

Peripheral treatment with the cholinergic agonist pilocarpine increases salivary gland blood flow and induces intense salivation that is reduced by the central injection of moxonidine (¦Á2-adrenoceptors/imidazoline agonist). In the present study, we investigated the effects of the intracerebroventricular (i.c.v.) injection of pilocarpine alone or combined with moxonidine also injected i.c.v. On submandibular/sublingual gland (SSG) vascular resistance. In addition, the effects of these treatments on arterial pressure, heart rate and on mesenteric and hindlimb vascular resistance were also tested.

Design

Male Holtzman rats with stainless steel cannula implanted into lateral ventricle and anaesthetized with urethane + ¦Á-chloralose were used.

Results

Pilocarpine (500 nmol/1 ¦Ìl) injected i.c.v. Reduced SSG vascular resistance and increased arterial pressure, heart rate and mesenteric vascular resistance. Contrary to pilocarpine alone, the combination of moxonidine (20 nmol/1 ¦Ìl) and pilocarpine injected i.c.v. Increased SSG vascular resistance, an effect abolished by the pre-treatment with the ¦Á2-adrenoceptor antagonist yohimbine (320 nmol/2 ¦Ìl). The increase in arterial pressure, heart rate and mesenteric resistance was not modified by the combination of moxonidine and pilocarpine i.c.v.

Conclusion

These results suggest that the activation of central ¦Á2-adrenoceptors may oppose to the effects of central cholinergic receptor activation in the SSG vascular resistance.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700